A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
2012 ◽
Vol 260
(4)
◽
pp. 984-997
◽
2010 ◽
Vol 32
(5)
◽
pp. 451-459
◽
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 18
(7)
◽
pp. 999-1012
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):